← SynDRA
CLINOFIBRATE
SynDRA canonical compound SYN0028070 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | LPL |
| Mechanism of action | Lipase clearing factor inhibitor |
| Indication | hypertriglyceridemia |
| Disease area | endocrinology |
All known targets
Mechanisms of action (all sources)
- Lipase clearing factor inhibitor
Cross-references
Synonyms
- lipoclin
- S 8527
- Clinofibrato
- Lipoclin
- Clinofibratum
- DTXCID4026638
- 1,1-bis(4'-(1''-carboxy-1''-methylpropoxy)phenyl)cyclohexane
- RefChem:577719
- MFCD00865769
- NCGC00167453-01
- NCGC00167453-02
- Clinofibrate [INN:JAN]
- Clinofibratum [INN-Latin]
- Clinofibrato [INN-Spanish]
- CAS-30299-08-2
- BRN 2230067
- UNII-0374EZJ8CU
- Lipoclin (TN)
- CLINOFIBRATE [MI]
- CLINOFIBRATE [INN]
- CLINOFIBRATE [JAN]
- Clinofibrate (JP18/INN)
- SCHEMBL31290
- CLINOFIBRATE [MART.]
- MLS006010186
- CLINOFIBRATE [WHO-DD]
- orb1300759
- CHEBI:31412
- HMS3656N09
- HMS5081H13
- Tox21_112457
- s2664
- AKOS015896391
- Tox21_112457_1
- AC-4728
- CCG-269436
- CS-6464
- NCGC00167453-03
Look up CLINOFIBRATE in the interactive SynDRA portal →